Several vaccines for HIV have been tested in animal studies and an early safety trial in people, showing promising results in ...

In a recent landmark study, scientists have unveiled how HIV-1 penetrates the cell's nuclear barrier—a discovery that could reshape antiviral strategies. The research, led by Professor Peijun Zhang, ...

When Wesley Sundquist first started researching the human immunodeficiency virus — HIV — he wasn’t seeking out a treatment. Rather, the chair of the University of Utah’s Department of ...

In a study of human immune cells infected with HIV, the virus that causes AIDS, scientists at Johns Hopkins Medicine say a molecule within HIV itself can be manipulated and amplified to force the ...

If the HIV virus enters a person’s body, lenacapavir is designed to disrupt the virus at several stages to undermine its ability to replicate and make that person sick.

Gilead Sciences has received US FDA approval for Yeztugo, its bi-annual HIV prevention injection, which has shown 96 per cent effectiveness in trials. Here's how it works, and what it costs.

FDA approves twice-a-year HIV prevention drug that could help end the virus worldwide It reduces transmissions by up to 96%, but now world governments and big-dollar funders will need to step in.

On May 30, a team of researchers funded by the National Institutes of Health got the word: Funding for their vaccine development program will end next year.

Designing an effective HIV vaccine has proven immensely challenging for researchers, who've spent decades working to figure out how to prompt the immune system to protect against this wily virus ...

Human immunodeficiency virus (HIV) is a germ that causes a lifelong infection that slowly weakens the immune system. Though the infection is lifelong, medicines can keep the virus in check and ...

A former top federal health official who served during President Trump’s first term warned that the drastic cuts to the Department of Health and Human Services (HHS) could have “devasta… ...

HIV-related deaths peaked in 1995, since then medication has significantly reduced the spread of the virus but the numbers are still on the rise in Dallas.